Djibouti vs Mozambique: Previously treated cases tested for RR-/MDR-TB
Djibouti
17.0%
in 2022
Mozambique
25.0%
in 2024
Djibouti rank
166th
Mozambique rank
164th
Previously treated cases tested for RR-/MDR-TB over time
- Djibouti
- Mozambique
How they compare
Mozambique currently reports 25.0% against 17.0% in Djibouti, a difference of 8.0%.
That makes Mozambique's figure about 1.5 times Djibouti's.
The two have swapped places 2 times across 8 shared years of data; in 2005 it was Mozambique ahead.
Djibouti ranks 166th and Mozambique ranks 164th of 180 countries.
Across the 3 decades both report, Djibouti averaged higher in 1 and Mozambique in 2.
Head to head by decade
| Decade | Djibouti | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 16.0% | 16.0% | Mozambique |
| 2010s | 73.8% | 45.6% | 28.3% | Djibouti |
| 2020s | 17.0% | 82.0% | 65.0% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Djibouti or Mozambique?
- Mozambique, at 25.0% against 17.0% in Djibouti as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Djibouti and Mozambique?
- 8.0%, with Mozambique ahead.
- How many years of comparable data are there for Djibouti and Mozambique?
- 8 years are reported by both, from 2005 to 2022.
- How do Djibouti and Mozambique rank globally for previously treated cases tested for rr-/mdr-tb?
- Djibouti ranks 166th and Mozambique ranks 164th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.